Comments
Loading...
REVANCE THERAPEUTICS INC COM Stock Guidance | NASDAQ:RVNC | Benzinga
REVANCE THERAPEUTICS INC COM issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 08/08/2024 | RVNC | Revance Therapeutics | FY | 2024 | — | — | — | $280.00M | — | $277.63M | Get Alert |
FAQ
What is the most recent guidance for REVANCE THERAPEUTICS INC COM (RVNC)?
There have been no specific sales or earnings guidance reported for REVANCE THERAPEUTICS INC COM in recent months.
Browse guidance and forecast on all stocks.